Capital World Investors
LKFT

Capital World Investors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Capital World Investors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,520
Closed -$451K – 611
2020
Q4 		$451K Buy
4,520
+666
+17% +$81.4K ﹤0.01% 560
2020
Q3 		$546K Buy
3,854
+54
+1% +$9K ﹤0.01% 549
2020
Q2 		$747K Buy
3,800
+1,203
+46% +$249K ﹤0.01% 519
2020
Q1 		$494K Buy
+2,597
New +$559K ﹤0.01% 502

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital World Investors's LKFT Position: Q1 2021 in Review

Capital World Investors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 4,520 shares — an estimated $451K sold.

Capital World Investors first reported a position in LKFT in Q1 2020 and held it in 4 quarters. The position peaked at $747K in Q2 2020. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.

  • Capital World Investors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Capital World Investors sold 4,520 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $451K.
  • Capital World Investors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 4 quarters.
  • Capital World Investors's Lakefront Biotherapeutics American Depositary Shares position peaked at $747K in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.

Based on Capital World Investors's 13F filing for Q1 2021, filed 14 May 2021.